Filing Flows › 8-K events › InMed Pharmaceuticals

InMed Pharmaceuticals: other events

Form 8-K filed Nov 5, 2026 · items 5.03, 5.07, 8.01

What the filing says

InMed Announces Results of 2026 Annual General and Special Meeting, Approval of Corporate Name Change and Completion of Share Consolidation Vancouver, British Columbia – November 4, 2026.

Read the filing on SEC EDGAR →

What usually followsAcross 5,869 8-Ks reporting Item 5.03 (charter or bylaw amendment) in our universe, the stock's median move the next session was +0.1% (typical size ±1.4%, up 52% of the time); over the following 21 sessions, +1.2%. Item 5.07: 0.0% next session across 16,815. Item 8.01: +0.1% next session across 44,881. Every item ranked →

Other recent mergers and acquisitions

• Starry Sea Acquisition Nov 6, 2026
• Kontoor Brands Nov 6, 2026
• Terawulf Nov 6, 2026
• Plains GP Holdings LP Nov 6, 2026
• Pono Capital Four Nov 6, 2026
• HeartSciences Nov 6, 2026
• Agility Robotics Nov 6, 2026
• Crown PropTech Acquisitions Nov 6, 2026
• Rallybio Nov 6, 2026
• Fox Nov 6, 2026

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.